Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma
{{output}}
Background: Hepatitis B virus (HBV) accounts for more than 60% of hepatocellular carcinoma (HCC) cases. However, there is limited information about the features of HBV-driven HCC that differentiate it from other types of HCC. ... ...
